Despite the smaller sample size, a clear trend in the outcomes of patients with a CD4 count >200 and ≤200 cells/μL was observed.
← all excerpts
Long-term Clinical Outcomes in Visceral Leishmaniasis/Human Immunodeficiency Virus-Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial.
1
—
—